
Photo: depositphotos.com
May 7, 2025, 09:10
Circulating Tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Solid Tumors Treated with Neoadjuvant ICIs
Dana-Farber’s Breast Oncology Center shared a post on X:
“Check out this recent Annals of Oncology ctDNA review and meta-analysis”
Title: Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis.
Authors: Carmine Valenza, E.F. Saldanha, Y. Gong, Pietro De Placido, David Gritsch, H. Ortiz, Dario Trapani, F. Conforti, C. Cremolini, S. Peters, J. Mateo, V. Subbiah, Heather Parsons, Ann Partridge, Giuseppe Curigliano
You can read the Full Article on ESMO Annals of Oncology.
More posts featuring Dana-Farber’s Breast Oncology Center.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 25, 2025, 10:12
May 25, 2025, 09:48
May 25, 2025, 08:33
May 25, 2025, 07:43
May 25, 2025, 07:04